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Ocimum sanctum (OS) is tropical herbal plant which is easy to find and widely used as a vegetable food in
Indonesia. In last decade, lung adenocarcinoma was in top position as male cancer disease in Indonesia. Recently,
emerging data showing the extracts of different species of Ocimum exhibiting the anti-tumor properties. Further
studies on lung lewis carcinoma demonstrated pro-apoptosis effects after the treatment with Ocimum extracts.
However, the effect of OS of Indonesian origin in human alveolar pulmonary adenocarcinoma A549 cells remain
unclear. Therefore, we aimed to investigate effects of ethanolic extract OS (EEOS) in A549 cell culture systems.
Cell adhesion and viability assays revealed that EEOS significantly decreased the attachment into extracellular
matrix of A549 cells. Morphological examination AO/EB and DAPI staining indicated that EEOS induced the cells
shrinkage, DNA fragmentation and condensation of A549 cells. Further, EEOS treatment induced the apoptosis
rate followed by up-regulation of reactive oxygen species (ROS), caspase-3 expression and decreased anti-
apoptotic protein Bcl-2. This condition also suppressed the expression of SOD2 as well as the GPx. In conclu-
sion, our findings indicate that EEOS suppressed the viability of A549 cells, which may result from the activation
of ROS promoting the apoptosis signaling via mitochondrial intrinsic pathway. Taken together, EEOS might be a
good therapeutic potential to further understand its properties in the treatment of lung carcinoma.1. Introduction
Lung alveolar pulmonary adenocarcinoma is one of the primary cause
of lung cancer in related to high mortality not only in developing coun-
tries but also worldwide [1, 2]. In Indonesia, lung cancer is on the first
position cause of death in cancer patients. The high prevalence of lung
adenocarcinoma in Indonesia is mainly due to smoking habits and also
industrial waste, such as fly ash, bottom ash, and coal ash [3]. Recently,
clinical therapies including surgery, chemotherapy, allopathy medicine
and radiotherapies are successful as concurrent therapeutic approaches
against lung cancer, however, several marked chances of undesirable and
adverse side effects caused by such therapies need to be managed [4].
Moreover, especially in developing countries, the therapeutic system isd (H. Wihadmadyatami).
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medicine in Indonesia.
The use of medicinal plants in chemoprevention is need to be
consideration as an ideal treatment with good efficacy and few side ef-
fects compared with allopathic medicine [5]. Recently, evidences have
shown that the prescription of new treatment methods that are derived
from plants or herbal medicine could reduce cancer mortalities until
25%, thus it proves that plants or herbal medicine plays an important role
in curing cancer symptoms and treatments [6, 7]. The use of herbal
remedies as complementary and alternative medicines (CAMs) has also
been widely used on United Kingdom (UK) and the rest of Europe such as
France and Germany, as well as in North America and Australia [8]. In
addition, dietary intake of phytochemicals as a chemoprevention agentsOctober 2019
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and has antitumor potential against lung cancer [9].
Basically, chemoprevention agents are compounds that prevent
development of cancer [10]. Their preventive effects are attributed to
intervening in interaction of the carcinogen with cellular DNA, altering
intracellular signaling pathways as results of stopping progression of an
initiated cell through pre-neoplastic changes into a malignant cell,
inhibiting angiogenesis, inducing cell cycle arrest, and triggering
apoptosis [11, 12, 13]. It is believed that the apoptosis induced by che-
moprevention agents may not only inhibit the carcinogenesis induced by
carcinogens, but also may suppress the growth of tumor and enhance the
cytotoxic effects of antitumor drug on tumor, which plays an important
role in the antitumor therapies [14].
The genusOcimum, belonging to the family Labiatae or Laminaceae, is
widely found in tropical and subtropical countries [15]. In Indonesia,
Ocimum sanctum is very easy to find and use commonly as vegetable food.
It is well-known that Ocimum sanctum acts as a chemopreventive,
anti-carcinogenic, free radical scavenger and also used as a medication
for neurodegenerative diseases [15, 16, 17, 18].
In recent years, there is a tremendous research work going on OS to
understand its additional pharmacological properties. For instance
ethanolic extract of Ocimum sanctum induced apoptosis of lewis lung
carcinoma [19], and aqueous extract of Ocimum gratissimum avoided the
breast cancer proliferation through inhibition of matrix metalloproteases
[20]. Further, Ocimum sanctum essential oil demonstrated in promoting
cytotoxic and apoptotic activity in human colorectal adenocarcinoma
cells [21]. It has been used in a variety of forms for consumption, the
aqueous leaf extract and seed oil are reported to show chemopreventive
and antiproliferative activity in Hela cells [22]. Ethanolic extract of
Ocimum sanctum (EEOS) leaf also has been shown to have a significant
influence on carcinogen metabolizing enzymes including cytochrome
P450, cytochrome b5, and aryl hydrocarbon hydroxylase [23, 24].
Additionally, Ocimum sanctum prepared in the form of fresh leaf paste,
aqueous, and ethanolic extract has been reported to reduce the incidence
of papillomas and squamous cell carcinoma in carcinogen-treated ham-
sters [25]. Nevertheless, how the mechanisms of ethanolic extract of
Ocimum sanctum (EEOS) underlying anticancer property remains unclear.
Therefore, in the present study, the anticancer effects of EEOS were
investigated using human lung carcinoma A549 cells.
2. Materials and methods
2.1. Preparation of Ocimum sanctum linn. ethanolic extract
O. sanctum leafs were derived from Center for Research and Devel-
opment of Medicinal Plants and Traditional Medicines, Ministry of
Health in Tawangmangu, Central Java, Indonesia. Crude extracts and
ethanolic extracts of O. sanctum were prepared as previously described
[15]. Then, the ethanolic extracts were diluted with phosphate buffer
saline (PBS) pH 7,4 to prepare there different concentrations (50 μg/ml,
70 μg/ml, 100 μg/ml) (Gibco, Waltham, MA, USA).
2.2. Cell culture of A549 cells
Lung adenocarcinoma cell A549 were maintained and cultured in
DMEM supplemented with FBS containing 100 g/ml penicillin/strepto-
mycin at 37 C in a humidified atmosphere. Cells were seeded in T-75
culture flask and grown to approximately confluence. EEOS treatments
were performed by incubating cells with several concentrations (50, 70,
100 ug/ml) of EEOS (w/v) in serum-free DMEM for 24 h. After the EEOS
treatments, the cells were washed with PBS pH 7,4 and collected for
following analyses.
2.3. Cell viability assay
Cell viability was determined by MTT assay as previously describe2
[17] in the absence or presence of 50, 70, 100 or 200 ug/ml EEOS. After
48 h treatments, culture medium was aspirated and cells were incubated
with MTT (0,5 mg/ml) at 37 C for 4 h. The viable cell number was
directly proportional to the production of formazan, which was dissolved
in isopropanol and determined by measuring the absorbance at 570 nm
using a microplate reader (SpectraMAX 360 pc, Molecular Devices,
Sunnyvale, CA).2.4. Adhesion assay
The adhesion assay are performed like previously describe [26, 27,
28]. Microtiter wells (Greiner Bio-one, Frickenhausen, Germany) were
coated with vitronectin (Athens Research and Technology, Athens, GA,
USA) or BSA (Serva, Heidelberg, Germany) in HBS buffer (119 mMNaCl,
4 mM KCl, 11 mM Glucose in 20 mM Hepes buffer) overnight at 4 C.
After washings, wells were then blocked with 100 μl 3% BSA for 1 h at 4
C. Aliquots of washed A549 cells (1-4 x106) were added together with
EEOS (final concentration 50 μg/ml, 70 μg/ml, and 100 μg/ml) for 1 h at
37 C. cRGD was run as positive control detachment. Wells were washed
once, and adherent cells were stained with crystal violet (Sigma, Stein-
heim, Germany) and measured in a microtiter reader at 592 nm (Sun-
rise™, Tecan, M€annedorf, Germany).2.5. Apoptosis assay
The apoptosis assay are performed like previously describe [26, 27,
28]. Cell apoptosis was measured by the Caspase-Glo 3/7 assay (Prom-
ega, Madison, WI, USA). 100 μl vitronectin (2 μg/mL; Athens Research &
Technology, Athens, GA, USA) were coated on 96 white well plates
(Corning Incorporated, Corning, NY, USA) for 8 h. Aliquots of 450 μl
A549 suspensions (1-2x106 cells in DMEMmedium) were incubated with
EEOS (final concentration 100 μg/ml), and cRGD (final concentration 20
μg/ml), then seeded onto vitronectin coated wells for 16 h at 37 C, 5%
CO2. 100 μl of Caspase-Glo 3/7 reagents were then added at room tem-
perature and luminescence was measured using a microtiter reader
(FLX800, Biotek Instrument Winooski, VT, USA).2.6. DAPI staining
DAPI staining was performed to assess morphological changes in the
chromatin structure of A549 cells undergoing apoptosis as previously
described [28]. Aliquots of 105 A549were seeded onto μ-slide well (Ibidi,
Martinsried, Germany) precoated with vitronectin (see above) together
with purified human IgG (final concentration 20 μg/ml), mab (final
concentration 20 μg/ml) and or cRGD (final concentration 20 μg/ml) for
16 h at 37 C, 5% CO2. After washings with 300 μl ice-cold PBS pH 7.4
(PAN, Aidenbach, Germany), cells were fixed with 300 μl 4% para-
formaldehyde (PFA; Sigma) for 15 min and incubated with 1 μg/ml blue
fluorescing dye (Hoechst 33342; Thermo Scientific, Rockford, IL, USA)
for 3 min at RT. Stained chromatin DNA condensation and fragmentation
was analysed using confocal microscopy with 60x magnification (Nikon
Eclipse TE2000-E, Tokyo, Japan).2.7. Acridine Orange/Ethidium Bromide staining (AO/EB)
A549 cells (1  105) were seeded in 24 well plate. Cells were incu-
bated in CO2 incubator with 37 C temperature and 5% CO2 then treated
with 100 μg/ml (final concentration) of EEOS re-incubate for 24 h. Cells
were fixed with 1 ml of 4% parafomaldehyde for 15–20 min in room
temperature. Cells were washed with PBS 1x for three times. Cells were
stained with Hoechst 10 μg/ml and Acridine Orange/Ethidium Bromide
(AO/EB) 10 μg/ml on each well and then incubated for 15 min in humid
chamber with 37 C temperature. Cells were washed with PBS 1x then
the cells were ready to be visualised by fluorescence invertedmicroscope.
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80% of confluent A549 cells in T75 flask were harvested with 3 ml
Trypsin-EDTA 0.25% then incubated for 3 min in the incubator at 37 C
temperature with 5% CO2. After the cells were detached from the flask,
growth medium was added to stop the trypsin. Cells suspension then
transferred into 15 ml centrifuge tube and centrifuge on 1600 rpm for 5
min. The supernatant was aspirated and the cells pellet were mixed in 5
ml growth medium. Cells were counted and 2.5  105 cells/0.5 ml
transferred into FACS round tube. The cells were centrifuged on 1600
rpm for 5 min. The supernatant was aspirated, the cell pellet was resus-
pended using DCFDA 1x bufferþ10% FBS. DCFDA 20 μMwas added into
cells suspension, then incubated for 45 min in the dark room maintaing
37 C temperature and 5% CO2. After incubation, cells were treated with
terbutyl hydroperoxide (TBHP) 250 μM (positive control), DCFDA 20 μM
(negative control), DMSO 10%, and Ocimum sanctum extract 100 μg/ml
for 4 h. ROS levels were measured using flow cytometer.
2.9. ELISA for caspase 9, caspase 3 and Bcl-2
The activity level of caspase 9, caspase 3, and Bcl-2 measured by
colorimetric assay kit (Abcam, Cambridge, MA, USA) according to the
manufacturer's protocol. Briefly, the cells were collected and resus-
pended in lysis buffer containing 50 mmol/L Hepes, pH 7.4, 0.1%
CHAPS, 1 mmol/L DTT, 0.1 mmol/L EDTA and 0.1% Triton X-100.
Following incubation for 30 min on ice, cell lysate was centrifuged at
11000 g for 10 min at 4 C, and the protein concentration in the super-
natants was measured using the Bradfordmethod. The supernatants were
incubated with reaction buffer containing 2 mmol/L Ac-DEVD-AFC for
caspase-3 and LEHD-AFC for caspase-9 (Abcam, Cambridge, MA, USA) in
a caspase assay buffer at 37 C with 10 mmol/L DTT for 30 min. Caspase
activity was determined by measuring the absorbance at 405 nm (Infinite
Pro 200, Tecan, Mannedorf, Switzerland). terbutyl hydroperoxide
(TBHP) 250 μMwas run as positive control. In the same way, 50 μL of the
sample were put on the 96 well, followed by adding 50 μL of the Bcl-2
antibody cocktail to each well. Incubate for 1 h at room temperature
on a plate shaker set to 400 rpm. Wash each well for three times, after the
last wash add 100 μL of TMB Substrate, incubate for 10 min. After last
incubation put 100 μL of stop solution to each well. The expression of Bcl-
2 was record on the OD at 450 nm. In all experiment, to correct the
nonspecific binding, backgrounds (negative control) were run for cell
lysate sample in parallel without the sampel. Cutoff values were deter-
mined as the mean signal of negative control (n¼ 10) plus three standard
deviations (SDs).
2.10. FOX assay
FOX reagent were composed of 100 uM xylenol orange (Merck,
Darmstadt, Germany), 250 uM ammonium ferrous sulfate (Sinopharm
Chemical Reagent, Shanghai, China), 90% methanol (Merck, Darmstadt,
Germany), 4 mM BHT (Acros Organics, New Jersey, USA) and 25 mM
H2SO4 (Merck, Darmstadt, Germany) Halliwell and Whiteman (2004)
and Rhee (2010) [29,30]. 50 ul sample were added to 550 ul FOX re-
agent. The samples were incubate at room temperature for 30 min then
read immediately at 460 nm.
2.11. ELISA superoxide dismutase (SOD2)
The assay is conducted using ELISA Superoxide Dismutase (SOD 2) kit
(Fine Test, Wuhan, China). The plate were washed 2 times before adding
standard, sample, and control (zero) wells. 100 ul standard or sample was
added to each well and incubate for 90 min at 37 C. Aspirate and wash
the plates 2 times. 100 ul Biotin-labeled SOD 2 antibodyworking solution
was added to each well and incubated for 60 min at 37 C. Aspirate and
wash the plates 3 times. 100 ul SABC working solution was added to each
well and incubated for 30 min at 37 C. Aspirate and wash the plates 53
times. 90 ul TMB substrate was added and incubated 15–30 min at 37 C.
50 ul stop solution was added, and read the plate at 450 nm immediately.2.12. ELISA glutathione peroxidase (GPx)
The assay is conducted using ELISA Glutathione Peroxidase 1 (GPX1)
kit (Fine Test, Wuhan, China). The plate were washed 2 times before
adding standard, sample, and control (zero) wells. 100 ul standard or
sample was added to each well and incubate for 90 min at 37 C. Aspirate
and wash the plates 2 times. 100 ul Biotin-labeled GPX1 antibody
working solution was added to each well and incubated for 60 min at 37
C. Aspirate and wash the plates 3 times. 100 ul SABC working solution
was added to each well and incubated for 30 min at 37 C. Aspirate and
wash the plates 5 times. 90 ul TMB substrate was added and incubated
15–30 min at 37 C. 50 ul stop solution was added, and read the plate at
450 nm immediately.2.13. Qualitative assay of phenolic and flavonoid by Thin Layer
Chromatography
The qualitative assay of phenolic was determined by putting 50 mg
sample into test tube and extracted by using vortex for 3 min and 1 ml
ethanol as solvent. Ethanol phase was aspirated then 20 ul sample was
spotted on silica gel plate (Merck, Darmstadt, Germany) including gallic
acid (Sigma Aldrich, St. Louis, USA) as comparation. The plate was put on
saturated chamber (CAMAG, Muttenz, Switzerland) with mobile phase,
the mix solution of 9.5 ml methanol (Merck, Darmstadt, Germany) and
0.5 ml formic acid 10% (Merck, Darmstadt, Germany), then elute until
the border. The plate was dry off, observed under UV light (Sankyo
Denki, Kanagawa, Japan), and spray using ferri chloride reagent (Merck,
Darmstadt, Germany). Subsequently, the same methode was run for the
flavonoid, with the modification of the comparation (quercetin) and the
mobile phase, the mix solution of 6.0 ml n-hexane (Merck, Darmstadt,
Germany), 4.0 ml ethyl acetate (Merck, Darmstadt, Germany), and 0.1 ml
formic acid (Merck, Darmstadt, Germany).2.14. Quantitative estimation of polyphenols
The total phenolic contents were determined using Folin-Ciocalteu
reagent (FCR) (Merck, Darmstadt, Germany) where as gallic acid
(Sigma Aldrich, St. Louis, USA) was used as a standard antioxidant. 50
mg sample were added to 0,5 ml FCR and diluted in 7,5 ml aquabidest,
followed by 10 min incubation in room temperature. 1,5 ml Na2CO3 20%
were added, then diluted with aquabidest until 10 ml. The solution were
diluted 25 times and transferred to the cuvette, the absorbance were read
at 760 nm using spectrophotometer (Shimadzu, Nagoya, Japan). Total
phenolic was expressed in % gallic acid equivalent/gram extract (% b/b).2.15. Quantitative estimation of flavonoids
The flavonoid content was determined using quercetin (Sigma
Aldrich, St. Louis, USA) as a standard antioxidant. 0,3 ml 5% natrium
nitrite was added to 0,05 g sample. After 5 min. 0,6 ml aluminium
chloride 10%were added and incubate for 5 min followed by 2 ml NaOH
1M addition and aquadest until 10 ml with volumetric flask. The solution
was diluted 50 times and transferred into cuvette. The absorbance was
recorded in spectrophotometer (Shimadzu, Nagoya, Japan) at 510 nm.
The total flavonoid content was expressed in % quercetin equivalent/





Fig. 1. EEOS induced detachment of A549 into
extracellular matrix (A) and decreased the viability of
A549 cells significantly (B). Adhesion assay (A) per-
formed by added the cells in the microtiter wells pre-
coated with vitronectin. After washing, adherent cells
were stained with crystal violet and measured in an
ELISA reader. MTT assay (B) performed by incubating
the cells in the presence of 50, 70, 100 or 200 ug/ml
EEOS. After 48 h treatments, the cells were incubated
with MTT 5 mg/ml for 4 h) at 37 C. The viable cell
number determined by measuring the absorbance at
570 nm using a microplate reader. Statistical analysis
was performed by one-way ANOVA followed by
Bonferroni's post-hoc test; n.s. ¼ not significant. cRGD
was used as a positive control anoikis.
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To address the beneficial use and the role of EEOS in the lung
adenocarcinoma, we investigated in the in vitro A549 cell culture model
system by the treatment of A549 cells with different concentrations of
OS. Cells adhesion to the extracellular matrix is a crucial part to guar-
antee the cells growth, survival, and communication. To analyze the
ability of EEOS-inducing A 549 cells detachment we performed adhesion
assay.3.1. EEOS induces detachment of A549 cells into extracellular matrix
A549 cells (3  105 cells/ml) were cultured on vitronectin coated
culture dishes and treated for 18 h with different concentrations of EEOS
(50 ug/ml, 70 ug/ml, 100 ug/ml). cRGD peptide (20 ug/ml) treated
A549 cells were used as a control. These cultures were subjected to
adhesion assay and interestingly, EEOS induces cell detachment in a dose4
dependent manner in A549 cells. The optimal concentrations of EEOS
with a dose of 100 ug/ml showed enormous cell detachment in com-
parison to the other concentrations. All of our experimental groups that
were treated with EEOS (50 ug/ml, 70 ug/ml, 100 ug/ml) inhibited the
binding of A549 onto immobilized vitronectin (Fig. 1A). Interestingly,
the higher concentration of EEOS 200 ug/ml reduced the ability to
inhibit gel attachment in comparison to the lower concentration of 70
ug/ml.3.2. EEOS decreases significantly the viability of A549 cells
In addition to adhesion assay, using this model we also performed the
viability assay. Similarly, the cells were treated with EEOS (50–200 μg/
mL) and the cell viability was assessed by the MTT. EEOS significantly
exhibited cytotoxic effect in human A549 cells, demonstrated with
%-mean viability decrement in a concentration dependent manner
(Fig. 1B) compared with the untreated control. In addition, EEOS at 100Fig. 2. EEOS induced apoptosis in A549
cells. (A) Caspase-Glo 3/7 assay was per-
formed by coated the vitronectin on 96 well
plate for 8 h, then aliquots of A549 suspen-
sions were incubated with EEOS and cRGD
then seeded into vitronection coated wells for
16 h. 10 μl of Caspase-Glo 3/7 reagents were
then added and luminescence was measured
using a microtiter reader. (B) DAPI staining
of A549 (NT, cRGD and 100 ug/ml EEOS)
were performed using confocal microscopy
with 60x magnification. (C) Acridine Orange-
Ethidium Bromide (AO/EB) Staining. 105
A549 cells were seeded in 24-well plate. Cells
were treated with 100 μg/ml (final concen-
tration) of EEOS then incubate for 24 h, fixed
with 1 ml of 4% parafomaldehyde for 15–20
min in RT. Cells were washed by PBS 1x,
stained with Hoechst and AO/EB (10 μg/ml),
incubated for 15 min. Cells were visualised
by fluorescence inverted microscope. Green
fluorescent represents viable cells, mean-
while orange fluorescent represents apoptotic
cells.
Fig. 3. EEOS promoted ROS production in A549 cells. 80% confluency of A549 in T75 flask were harvested with trypsin-EDTA 0,25%. Cells were counted and 2.5 
105 cells/0.5 ml transferred into FACS round tube. The cells were centrifuged on 1600 rpm for 5 min. The supernatant was aspirated and the pellet was resuspended
using DCFDA 1x buffer þ10% FBS. After incubation, cells were treated as follows. Cell only, TBHP 250 μM (positive control), DCFDA 20 μM (negative control), DMSO
10%, Ocimum sanctum extract 100 μg/ml. Cells were incubated for 4 h on 37 C temperature and 5% CO2. ROS levels were measured using flow cytometer.
Fig. 4. EEOS treatment promoted oxidative stress in A549 cells. FOX assay was performed to answer that the cytotoxicity induced by EEOS is due to ROS generation.
The cells were collected and resuspended in lysis buffer. 50 ul cell lysate were added to 550 ul FOX reagent. The samples were incubate at room temperature for 30
min then read immediately at 460 nm.
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comparable to its positive control cRGD, while non-treated cells did not
show any significant cytotoxicity as a negative control. Interestingly, the
treatment of A549 cells with 200 μg/mL EEOS demonstrate less but still
still exhibiting significant cytotoxic effect in A549 cancer cells.Fig. 5. EEOS regulated apoptosis correlation to proteins in A549 cells. (A) Caspase 9
measured by colorimetric assay kit. The cells were collected and resuspended in lysi
protein concentration in the supernatants was measured using the Bradford method.
DEVD-AFC for caspase-3 and LEHD-AFC for caspase-9 (Abcam) in a caspase assay buff
measuring the absorbance at 405 nm. Statistical analysis was performed by one-way
5
3.3. EEOS treatment induced apoptosis and promote ROS production in
A549 cells
To demonstrate the anticancer effect of EEOS in A549 cels, we per-
formed an apoptosis assay by using caspase-Glo 3/7. Indeed, this
experiment showed that the EEOS treatment induced apoptosis in A549(B) Caspase 3 and (C) Bcl-2. The activity level of Caspase 9, Caspase 3, and Bcl-2
s buffer. The cell lysate was centrifuged at 11000 g for 10 min at 4 C, and the
The supernatants were incubated with reaction buffer containing 2 mmol/L Ac-
er at 37 C with 10 mmol/L DTT for 30 min. Caspase activity was determined by
ANOVA followed by Bonferroni's post-hoc test; n.s. ¼ not significant.
Fig. 7. The ingredient of EEOS based on Thin Layer Chromatography. (A) Flavonoid (Rf: 0,54; 0,84; 0,98) and (B) phenolic compound (Rf: 0,85) are positively
contained in EEOS. The qualitative assay of phenolic was determined by putting 50 mg sample into test tube and extracted by using vortex and ethanol as solvent.
Ethanol phase was aspirated then sample was spotted on silica gel plate including gallic acid as standard. The plate was put on saturated chamber with mobile phase
then elute until the border. The plate was dry off, observed under UV light and spray using ferri chloride reagent. Subsequently, the same methode was run for the
flavonoid with quercetin as standard.
Fig. 6. EEOS suppressed antioxidant enzyme activity, (A) SOD and (B) GPx. Enzyme-linked immunosorbent assay was performed to describe SOD and GPX activity.
The cells were collected and resuspended in lysis buffer. The cell lysate were tested using SOD and GPx ELISA kit. SOD and GPx activity were determined by measuring
the absorbance at 450 nm.
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positive control (Fig. 2A and B). Since the concentration of EEOS 200 ug/
ml did not show the results with adhesion and viability assay, therefore,
this concentration was not included in this experiment. In addition, DNA
fragmentation analysis by DAPI staining also showed significant cell
shrinkage and DNA fragmentation in the 100 ug/ml EEOS treated cells in
comparison to the control cells (Fig. 2B). Those findings are further
confirmed by Hoechst 33342 and acridine orang/ethidium bromide (AO/
EB) staining (Fig. 2C). It's found that only less cells exhibit blue fluo-
rescence of Hoechst 33342 on EEOS treatment which means the
apoptosis rate of EEOS treatment group is higher than control group.
Acridine orange/ethidium bromide staining also can be seen qualita-
tively that AO/EB control cells exhibit green colours. Green colour cells
represents normal, viable and non-apoptotic cells. On the other hand,
EEOS treatment group exhibit orange fluorescent that represent
apoptotic cells. It is known that disruption of cell adhesion into extra-
cellular matrix results in detachment-induced apoptosis, termed anoikis,
which is associated with increased intracellular ROS level.
To analyze whether EEOS can also trigger A549 anoikis, the gener-
ation of intracellular ROS induced by EEOSwas measured by oxidation of
DCFDA using flow cytometry. As shown in Fig. 3, ROS production was
increased in a dose-dependent manner and optimumwas at 100 ug/ml in
EEOS treated cells as well as in the control group treated with trybutil
hydroperoxide (TBHP). To exclude the involvement of cell culture me-
dium components interactions with EEOS in inducing the cytotoxic ef-
fect, we performed the Fox Assay. Our results showed clearly that, there
was no difference or very low effect in the hydrogen peroxide6
concentrations in the both medium non treated and treatment (NT vs
EEOS 50 μg/mL vs EEOS 70 μg/mL vs EEOS 100 μg/mL vs 200 μg/mL:
0.1513 vs 0.1510 vs 0.1222 vs 0.1092 vs 0.1321) (Fig. 4).
3.4. EEOS regulated apoptosis correlation to proteins in A549 cells
Since increased ROS levels can disrupt the mitochondrial membrane
potential thereby activating the apoptosis signaling pathway by
involving the differential activity of different enzymes namely caspases.
Therefore, in this study, pro-apoptotic and anti-apoptotic activities were
analyzed in EEOS treated A549 cells. Interestingly, EEOS-treatment
derived ROS might disrupt the mitochondrial membrane potential and
activated caspase 9 and caspase 3 as shown in Figs. 5A and B. This
increased activity might promote the cleaved caspase-mediated PARP
cleavage in A549 cells. In addition, EEOS-treatment in A549 cells
decreased the activity of anti-apoptotic protein Bcl-2 in a concentration
dependent manner (Fig. 5C). These data imply that EEOS treatment in
A549 cells increases the ratio of Bax protein suggesting the activation of
apoptotic pathway than survival or anti-apoptotic signaling mechanism
(Fig. 5). These data suggest that EEOS induces apoptosis via activation of
caspases and inhibition of anti-apoptotic protein in A549 cells.
3.5. Oxidative stress induce by EEOS decrease the activity of antioxidant
enzyme
The main antioxidant defense enzymes that contribute in reducing
the oxidative stress are superoxide dismutase (SOD) and glutathione
H. Wihadmadyatami et al. Heliyon 5 (2019) e02772peroxidase (GPx). Since the EEOS induced apoptosis and promote ROS
production in A549 cells, we performed an ELISA assay to describe the
activity of SOD and GPx. Our results demonstrated that, SOD2 activity
was gradually decreased, however at the concentration of 200 μg/mL
there was slightly increased level was detected (Fig. 6A). In addition, we
observed a gradual decrease of GPx-activity during the treatment of
cancer cells during increased EEOS concentration (from 50 ug/ml to 100
ug/ml) (Fig. 6B).
3.6. The EEOS contain abundant polyphenol and flavonoid
The experimental analysis on the TLC found that on the EEOS contain
abundant polyphenol (12.50 % b/b) and flavonoid (28.22%b/b) (Fig. 7).
4. Discussion
Recently, several species of genus Ocimum are already in use as a
herbal medicine not only in Asia but also in Europe and North America
[31]. Some evidences indicate that Ocimum extracts possess antitumor
effects [11, 12, 13, 14]. Moreover, Ocimum sanctum combining with
Azadirachta indica was reported to have a synergistic chemopreventive
effects on chemical-induced gastric carcinogenesis [32]. These studies
illustrate the importance of OS as an anti-oxidant, anti-angiogenic, and
anti-proliferative. Over the years, the herbal usage has been increased
many folds and the conventional medical usage also showed the positive
results [8]. Therefore, we hypothesized that EEOS might exhibit bene-
ficial effects in lung adenocarcinoma. However, there is no information
about the mechanisms of the anticancer effect from ethanolic extract
Ocimum sanctum (EEOS) in lung adenocarcinoma cells. In the present
study, we investigated to understand the anticancer effects of EEOS in
A549 cell culture model system.
We showed that the EEOS derived from the leaf of Ocimum sanctum is
dose dependent (100 ug/ml). Based on our experiments, the adhesion
and viability assays revealed that EEOS promoted cell detachment and
decreased the cell viability at 100 ug/ml (Fig. 1A and B). It has been
documented that cell adhesion to extracellular matrix (ECM) is essential
for cell proliferation and survival [33]. Inhibition of cell adhesion that
disrupt the ligation between αvβ3 on the cell surface and vitronectin lead
to cell anoikis [34] and subsequently to cell apoptosis [35, 36, 37, 38]. In
this experiments, we use Cyclic synthetic peptides containing the
arginine-glycine-aspartate motif (cRGD) as a positive control to promote
cell detachment and cell death. The cRGD targeted for integrin αvβ3,
integrin αvβ3 plays a significant role in tumor angiogenesis and is a re-
ceptor for the extracellular matrix proteins with the expose of RGD tri-
peptide sequence. The αvβ3 integrin expressed on the tumoral
endothelial cells as well as on the tumor cells [39, 40]. It has been shown
the cRGD able to inhibit adhesion of various cells to several extracellular
matrix proteins including fibronectin, vitronectin, von Willbrand factor,
fibrinogen, thrombospondin and osteopontin. cRGD will strongly block
cell attachment to the extracellular matrix and lead to cell death [26, 41].
Kim and colleagues also reported the inhibitory effect of ethanol leaf
extract of O. sanctum extract on lung metastasis using the mouse LLC
cells. Ethanol leaf extract of O. sanctum extract prevented cell adhesion
and invasion of LLC cells to extracellular matrix (ECM) [42].
Furthermore, to analyze its role in apoptosis, we performed an
apoptotic assay. Interestingly, we found that the EEOS induced apoptosis
in A549 cells (Fig. 2), in agreement to the results, our ROS analysis in the
presence of EEOS also showed a significant increase in ROS (Fig. 3). In
line with these results, cell detachment is normally associated with the
activation of mitochondria to produce reactive oxygen species (ROS). It is
well known that ROS can initiate and regulate the transcription and
activation of different mediators which culminate in the common
mechanism of cell damage via apoptosis caspase pathway [43]. In
addition, ROS is known to cause oxidative modification of DNA, proteins,
lipids and cellular small molecules [44]. Increased ROS levels are thought
to constitute an essential step in apoptotic induction. Apoptosis or7
programmed cell death has two well known pathways, extrinsic and
intrinsic pathways. In the case of the intrinsic pathway, a release of cy-
tochrome C from mitochondria results in binding to Apaf-1 and subse-
quently leads to activation of procaspase-9 and following caspase-3.
Activated caspase-3 exerts as the key executioner of apoptosis to induce
the cleavage and inactivation of key cellular protein [43, 45]. In the
present study, EEOS treatment demonstrated the increasing of caspase-3
expression level (Fig. 5), meanwhile this substance depressed the activity
of anti-apoptotic protein Bcl-2. There is an evidence that early event in
apoptosis is occur by the disruption of the mitochondrial membrane
potential.
Apoptosis also contributes to morphological changes of some features
inside the cells. The morphological features of apoptosis consist of
chromatin condensation, nuclear fragmentation, an increase cell density
and the formation of cytoplasmic blebs. The nucleus acquires an irregular
shape, nucleolar size increases and its granules become enlarged and
spread out [46]. The final stage of apoptosis is characterized by DNA
degradation and cell damage into dense membrane-surrounded frag-
ments (apoptotic bodies). Some apoptotic bodies contain fragments of
the nucleus, while others contain only cytoplasm [47]. Therefore, nuclear
condensation can be used to determined apoptotic cells from healthy
cells or necrotic cells. Dyes that bind to DNA, such as Hoechst 33342, can
be used to observe nuclear condensation (Fig. 6). Cells that have died by
apoptosis will generally display condensed DNA and fragmented nuclei,
meanwhile the healthy and necrotic cells do not [48]. Dual AO/EB
fluorescent staining also detect basic morphological changes in apoptotic
cells and necrotic cells on A549 treated with EEOS (Fig. 6). Liu et al. 2015
proposed that AO penetrated normal and early apoptotic cells with intact
membranes, fluorescing green when bound to DNA. EB only entered cells
with damages membranes, such as late apoptotic and dead cells, emitting
orange-red fluorescence when bound to concentrated DNA fragments or
apoptotic bodies [49].
To strengthen our results, we performed the antioxidant enzymes
activities for SOD2 and GPx. SOD drives the reaction of dismutation of
superoxide into hydrogen peroxide. The SOD2 or also known as
manganese-dependent superoxide dismutase (MnSOD) is mainly local-
ized in the mitochondria [50, 51] and the first detoxification enzyme.
However, MnSOD overexpression is common in tumors and contribute to
therapy resistance [52]. From the results we can see the gradually
decreasing level of SOD2 meanwhile on the concentration EEOS at 200
μg/mL there is slightly increasing level of SOD2. Since mitochondria are
the major source of reactive oxygen species, decreasing their detoxifying
ability by means blocking SOD2 activity in cancer might contribute to
induce apoptosis [50]. Plumbagin proved to efficiently induce apoptosis
in effect in prostate cancer cell lines, partially through decreasing SOD2
expression [53]. Phenethyl isothiocyanate was found to inhibit expres-
sion of SOD2 in LN229 glioma cell line, weakening cellular antioxidant
defense and causing apoptosis [54]. Suppression of SOD2 enzymatic ac-
tivity by apigenin in combination with ROS-inducing paclitaxel was
found to sensitize HeLa cells to apoptosis and allowed to lower paclitaxel
doses [55]. Apigenin is one of chemical constituent which presents in
Ocimum sanctum extract. It had been reported that apigenin could form
stabel complexation with metal ions in vitro [56] and decrease SOD ac-
tivity by blocking SOD from assemble with its cofactors. It has been
addressed that apigenin was a potential inducer of intracellular oxidative
stress [57].
In addition, we perform an ELISA assay for glutathione peroxidase
(GPx). The GPx is a enzymatic scavenger of proxides (H2O2), thus H2O2
can be detoxified by GPx and converted into H2O [58, 59]. The clinical
importance of GPx has been underlined by a number of studies.
Increasing level of GPx can protect the cells against hydrogen peroxide
induce cell death or apoptotic, meanwhile depletion or silencing GPx
may suppresses cell cancer growth [60]. In addition, lower GPx activity is
predisposed to impaired antioxidant protection, which leads to oxidative
damage to the cancer cells [61]. Forgione and colleagues [62] had pre-
viously hypothesized that GPX deficiency directly induces an increase in
H. Wihadmadyatami et al. Heliyon 5 (2019) e02772vascular oxidative stress, with attendant endothelial dysfunction. Based
on our GPx experimental results, we observe gradual decrement of
GPx-activity during the treatment of cancer cells with increased EEOS
concentration (from 50 ug/ml to 100 ug/ml). These results indicated that
specific EEOS concentration presumably induced the increases of the
lipid peroxidation, which therefore prevent it's enzymatic activity, and
prevent the cytoprotective effect of cancer cells. Interestingly, the
GPx-activity-inhibition effect was abolished by the treatment of high
dose EEOS (200 ug/ml), To answer the phenomenon that the EEOS at
200 ug/ml is always less effective than lower concentrations, we did an
experiment by Thin Layer Chomatography (TLC) to analyse the ingre-
dient of the EEOS. Based on the TLC results the EEOS contain abundant
polyphenol (12.50 % b/b) and flavonoid (28.22%b/b) on the EEOS
(Fig. 7). Our data is in line with the other research before, which is
mention the EEOS contained many substances consisting of apigenin,
luteolin, apigenin-7-O-β-D-rutinopyranoside, luteolin-7-O- β-D-gluco-
pyranoside, vicenin-2, vitexin, isovitexin, orientin, isoorientin, aescule-
tin, aesculin, chlorogenic acid, eugenol, and caffeic acid [63, 64, 65].
Phenol and flavonoids have gained importance as anti-cancer agents and
have shown great potential as cytotoxic anti-cancer agents promoting
apoptosis in cancer cells [66]. Danciu et al. [67] reported the increase in
anticancer activity was correlated with the increase in amount of poly-
phenol compounds. Moreover, the results from many biomedical
research teams indicated that various kinds of flavonoids can promote
apoptosis in various cancer cells [68, 69, 70]. Presumably, some sub-
stances such as eugenol induced general protective effects [64, 71, 72],
and in contrary, some substance such as flavonoid and phenol is well
known as specific cancer cells inhibiting agents, both in different oppo-
site effective dose dependent functionality, and could causes different
physiological mechanism within different doses. It is likely that this
reason causes EEOS to be less effective at a concentration of 200 ug/ml
due to the work imbalance of the active substance. Thus it is important to
separate the active substance from EEOS to be able to optimize the
cytotoxicity function of EEOS.
In conclusion, the present study demonstrates the significant evidence
of EEOS treatment in altering the viability of lung adenocarcinoma A549
cells through a synergy of induction of apoptotic signaling via intrinsic-
mitochondria pathway. Further research is needed to isolate the phyto-
chemicals that are responsible for cancer cell apoptosis.
5. Conclusion
Taking together, our results showed that EEOS provide anticancer
activity by decreasing cell proliferation and viability, increasing intra-
cellular ROS, interfere the activity of SOD and GPx thus promoting
apoptosis in A549 cells. The results derived from our investigation
confirmed the therapeutic potency of EEOS.
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